Three quarters of a mile from civilization

Views, analysis & commentary - essentially on venture capital & pharmaceutical industry

Showing posts with label Price Rationalization. Show all posts
Showing posts with label Price Rationalization. Show all posts
Sunday, March 31, 2013

Factors Influencing the Global Prospects & Investor Attractiveness of Indian Pharmaceutical Industry

›
Most ‘Indian Pharma Outlook’ reports from the likes of McKinsey & PwC   almost exclusively focus their policy & regulatory scen...
3 comments:
Friday, January 25, 2013

3200% premium for innovation!!

›
April 2012 Discussion posted on Pharmaceutical Discussion Group on Linkedin http://www.linkedin.com/groups/PhRMA-says-price-as-trig...

Why won't Gates spend a few more cents (per dose) on non-mercury biocides & shut-up the vaccine detractors?

›
April 2012 Discussion posted on Pharmaceutical Discussion Group on LI - by Murali Apparaju http://www.linkedin.com/groups/Why-wont-G...
1 comment:
›
Home
View web version
Powered by Blogger.